Indication
Dermatomyositis
The Dermatomyositis pipeline: 3 tracked drugs, 1 approved for this indication.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Dermatomyositis, so this list is not complete.
1 approved / phase 41 Phase 21 Phase 1/2
Compare the share prices of listed companies in Dermatomyositis →
Market size not yet sourced. How markets are sized ↗